← Back to the fund page Use your browser's print dialog and choose “Save as PDF”. A4.
InvestVerdict

Abakkus Flexi Cap Fund

Regular Plan · Growth · Flexi Cap · Scheme code 154041

NAV₹10.3180as on 28 Oct 2026
Fund houseAbakkus Mutual Fund
CategoryFlexi Cap
Plan & optionRegular · Growth
History0.7 years

Returns (%)

 1M3M6M1Y3Y5Y7Y10YLaunch
This scheme 3.769.8213.30 ——— ———
Nifty 500
benchmark		 0.874.312.15 5.2012.4911.41 ——15.49
Flexi Cap
category median		 ——— -7.3010.387.65 —11.52—

Over a year annualised (CAGR), under a year absolute. Computed from AMFI's published NAV history for this scheme.

Risk

 VolatilitySharpeSortinoBetaAlphaMax fallR²
This scheme — — — — — -10.8% —
Nifty 500
benchmark		 15.2%0.39 0.58—— -37.3%—

Risk-free rate 6.5%. Beta, alpha and R² are regressed on the — months this scheme and its benchmark share.

Growth of ₹100 since launch

89981071152026InvestVerdict

Drawdown from peak (%)

0%-4%-8%-12%2026

Every one-year period it has lived through

WindowsWorstMedianBestPeriods that lost money
0 — — — —

Every one-year holding period in this scheme's history, not just the last one — the spread a real investor would have met depending only on when they started.

InvestVerdict

Abakkus Flexi Cap Fund

Regular Plan · Growth

Allocation

By asset

Equity94.08%
Cash & Equivalents5.73%
Debt0.19%

By market cap

Large Cap45.19%
Mid Cap19.21%
Small Cap28.42%
Unclassified1.45%

Concentration

Number of stocks48
Top 5 stocks19.30%
Top 10 stocks32.88%
Top 20 stocks56.52%
Lines in the filing50
Largest holding4.97%
Largest sectorBanks 15.79%
Effective stocks43.5
Sectors held27
Cash5.73%

Effective stocks is what the concentration works out to: a fund holding 48 names but most of its money in a few behaves like a fund of 44. Cash includes repo and TREPS, which every fund parks money in overnight.

Sector split

Banks — 15.8%Pharmaceuticals & Biotechnology — 8.9%Capital Markets — 7.2%Cash & Equivalents — 5.7%Finance — 5.1%Power — 4.2%Consumer Durables — 3.8%Electrical Equipment — 3.8%Industrial Products — 3.8%Other — 41.9%Banks15.8%Pharmaceuticals & Biotech…8.9%Capital Markets7.2%Cash & Equivalents5.7%Finance5.1%Power4.2%Consumer Durables3.8%Electrical Equipment3.8%Industrial Products3.8%Other41.9%
Banks15.79%
Pharmaceuticals & Biotechnology8.91%
Capital Markets7.15%
Cash & Equivalents5.73%
Finance5.09%
Power4.17%
Consumer Durables3.76%
Electrical Equipment3.76%
Industrial Products3.75%
Agricultural, Commercial & Construction Vehicles3.59%
Chemicals & Petrochemicals3.41%
Automobiles3.27%
Retailing3.04%
Petroleum Products2.91%
Construction2.88%
Telecom - Services2.74%
Auto Components2.72%
Leisure Services2.61%
Non - Ferrous Metals2.45%
Ferrous Metals2.00%
InvestVerdict

Abakkus Flexi Cap Fund

Regular Plan · Growth · holdings

Top 30 holdings

#CompanySectorShares held Value
₹ cr		% of fund
1 Triparty Repo Unclassified — 479 6.10%
2 ICICI Bank Limited Banks 2,950,000 390 4.97%
3 HDFC Bank Limited Banks 5,000,000 354 4.52%
4 State Bank of India Banks 3,000,000 288 3.67%
5 NTPC Limited Power 7,850,000 253 3.23%
6 Reliance Industries Limited Petroleum Products 1,925,000 229 2.91%
7 Larsen & Toubro Limited Construction 600,000 226 2.88%
8 Indus Towers Limited Telecom - Services 5,750,536 215 2.74%
9 ZF Commercial Vehicle Control Systems India Limited Auto Components 912,517 214 2.72%
10 The Federal Bank Limited Banks 6,500,000 206 2.63%
11 Leela Palaces Hotels & Resorts Limited Leisure Services 3,569,337 205 2.61%
12 ICICI Prudential Asset Management Company Limited Capital Markets 644,033 202 2.58%
13 Aether Industries Limited Chemicals & Petrochemicals 1,185,000 201 2.57%
14 Dixon Technologies (India) Limited Consumer Durables 150,000 197 2.51%
15 Inox India Limited Industrial Products 950,000 195 2.49%
16 360 One WAM Limited Capital Markets 1,875,000 193 2.46%
17 Vedanta Aluminium Metal Limited Non - Ferrous Metals 4,650,000 192 2.45%
18 Lupin Limited Pharmaceuticals & Biotechnology 900,000 183 2.33%
19 Billionbrains Garage Ventures Ltd Capital Markets 9,000,000 166 2.11%
20 Mahindra & Mahindra Limited Automobiles 550,000 162 2.07%
21 Ajanta Pharma Limited Pharmaceuticals & Biotechnology 447,651 162 2.07%
22 Divi's Laboratories Limited Pharmaceuticals & Biotechnology 170,000 158 2.01%
23 Tata Steel Limited Ferrous Metals 8,500,000 157 2.00%
24 Tata Motors Ltd Agricultural, Commercial & Construction Vehicles 3,700,000 156 1.99%
25 DLF Limited Realty 2,300,000 155 1.98%
26 United Spirits Limited Beverages 1,100,000 149 1.90%
27 CG Power and Industrial Solutions Limited Electrical Equipment 1,729,616 148 1.88%
28 Emmvee Photovoltaic Power Limited Electrical Equipment 4,665,000 147 1.88%
29 IIFL Finance Limited Finance 2,400,000 144 1.84%
30 Edelweiss Financial Services Limited Finance 9,005,000 129 1.64%
InvestVerdict

Abakkus Flexi Cap Fund

Regular Plan · Growth · where the money sits

What the manager did last month

Between the filings of 30 Jun 2026 and 31 Jul 2026. A position grows because the manager bought or because the price rose; only the share count separates them.

BoughtSoldNew positionsSold out ofPrice move of holdings
₹991 cr ₹53 cr 1 1 +2.61%
StockShares tradedShares PriceValue
₹ cr
New position
International Gemological Institute Limited 1,094,184 entered — 38.7
Added to
NTPC Limited 2,650,000 +126.2% -2.6% 92.0
Vedanta Aluminium Metal Limited 1,300,000 +54.2% +1.3% 59.1
PB Fintech Limited 345,000 +86.3% -1.7% 55.3
State Bank of India 525,000 +28.0% +0.1% 53.9
Larsen & Toubro Limited 136,636 +71.9% -4.9% 53.8
Ajanta Pharma Limited 149,384 +68.0% +1.2% 51.8
ICICI Bank Limited 350,000 +16.7% +4.4% 50.2
ZF Commercial Vehicle Control Systems India Limited 198,581 +44.1% -5.8% 48.0
Trimmed
Avalon Technologies Limited 116,224 -20.8% +0.3% 21.0
Cyient Dlm Ltd 256,631 -15.3% +45.6% 17.2
Bajaj Auto Limited 13,114 -13.1% +18.6% 15.1
Sold out of
Bank of Baroda 5,200,000 exited — 142
Not equityPrevious filingThis filingChange
Cash, repo and TREPS ₹0 cr ₹0 cr +₹0 cr
Debt: bills, CDs and commercial paper ₹25 cr ₹25 cr +₹0 cr

The list above is stocks and fund units. Treasury bills, repo and money-market lines roll over every month by design — they are not decisions, so they are totalled here rather than listed as activity.

Not investment advice. InvestVerdict is not a SEBI-registered Investment Adviser or Research Analyst. Every figure is computed from AMFI's published NAV history and the portfolio the AMC filed with AMFI; none of it is a recommendation to buy, hold or sell. Past returns do not predict future ones. Generated 30 Oct 2026.